Pancreatic Cancer Research

ResearcherEast Carolina UniversityNo recent work listed

Michael A. White

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-8511-6026; OpenAlex author ID A5066016110. Sources: OpenAlex.

Their work

Papers
3
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2011: 1 paper · 2012: none · 2013: none · 2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: 1 paper

Papers 3

  1. Development of improved therapeutic mesothelin-based vaccines for pancreatic cancer. Co-author DOI 10.1371/journal.pone.0193131↗
  2. MCT4 defines a glycolytic subtype of pancreatic cancer with poor prognosis and unique metabolic dependencies. Co-author DOI 10.1016/j.celrep.2014.11.025↗
  3. Impact of pancreatic cancer and subsequent resection on glycemic control in diabetic and nondiabetic patients. Co-author DOI 10.1177/000313481107700823↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Emmanuel E. Zervos · 2 shared papers, 2011–2018 · strength 0.14
  2. Rachel L. Roper · 1 shared paper, 2018 · strength 0.11
  3. GuemHee Baek · 1 shared paper, 2014 · strength 0.04
  4. Erik S. Knudsen · 1 shared paper, 2014 · strength 0.04
  5. Agnieszka Katarzyna Witkiewicz · 1 shared paper, 2014 · strength 0.04
  6. Charles J. Yeo · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.